Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Therapie
|
January 21, 2026
Clémentine Body, Frédéric Chassagnol, Driss Berdaï, et al.
Therapie
|
January 4, 2026
How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?
Clémentine Body, Frédéric Chassagnol, Driss Berdaï, et al.
Therapie
|
July 10, 2016
[Not Available]
Benoît Dervaux, Karine Szwarcensztein, Anne Josseran, et al.
Therapie
|
March 10, 2015
Assessment and non-clinical impact of medical devices
Benoît Dervaux, Karine Szwarcensztein, Anne Josseran, et al.
Therapie
|
August 29, 2013
Scientific evaluation and pricing of medical devices and associated procedures in France
Martine Gilard, Frederique Debroucker, Claude Dubray, et al.
Therapie
|
July 10, 2016
[Not Available]
Martine Gilard, Frédérique Debroucker, Claude Dubray, et al.
Therapie
|
November 29, 2022
Gérard de Pouvourville, Xavier Armoiry, Aurélie Lavorel, et al.
Therapie
|
December 4, 2022
Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials?
Gérard de Pouvourville, Xavier Armoiry, Aurélie Lavorel, et al.
Therapie
|
September 18, 2014
Telemedicine: what framework, what levels of proof, implementation rules
Faiez Zannad, Philippe Maugendre, Antoine Audry, et al.
Therapie
|
March 14, 2018
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases
Driss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Therapie
|
January 21, 2026
Clémentine Body, Frédéric Chassagnol, Driss Berdaï, et al.
Therapie
|
January 4, 2026
How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?
Clémentine Body, Frédéric Chassagnol, Driss Berdaï, et al.
Therapie
|
July 10, 2016
[Not Available]
Benoît Dervaux, Karine Szwarcensztein, Anne Josseran, et al.
Therapie
|
March 10, 2015
Assessment and non-clinical impact of medical devices
Benoît Dervaux, Karine Szwarcensztein, Anne Josseran, et al.
Therapie
|
August 29, 2013
Scientific evaluation and pricing of medical devices and associated procedures in France
Martine Gilard, Frederique Debroucker, Claude Dubray, et al.
Therapie
|
July 10, 2016
[Not Available]
Martine Gilard, Frédérique Debroucker, Claude Dubray, et al.
Therapie
|
November 29, 2022
Gérard de Pouvourville, Xavier Armoiry, Aurélie Lavorel, et al.
Therapie
|
December 4, 2022
Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials?
Gérard de Pouvourville, Xavier Armoiry, Aurélie Lavorel, et al.
Therapie
|
September 18, 2014
Telemedicine: what framework, what levels of proof, implementation rules
Faiez Zannad, Philippe Maugendre, Antoine Audry, et al.
Therapie
|
March 14, 2018
Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases
Driss Berdaï, Florence Thomas-Delecourt, Karine Szwarcensztein, et al.
Page
of 2